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Abstract Neonatal and paediatric
intensive care has improved the
prognosis for seriously sick infants
and children. This has happened be-
cause of a pragmatic approach fo-
cused on stabilisation of vital func-
tions and immense technological ad-
vances in diagnostic and therapeutic
procedures. However, the belief that
more medical care must inevitably
lead to improved health is increas-
ingly being questioned. This issue is
especially relevant in developing
countries where the introduction of
highly specialised paediatric inten-
sive care may not lead to an overall
fall in child mortality. Even in de-
veloped countries, the complexity
and availability of therapeutics and
invasive procedures may put seri-
ously ill children at additional risk. In
both developing and industrialised
countries the use of safe and simple
procedures for appropriate periods,
particular attention to drug prescrip-
tion patterns and selection of appro-
priate aims and modes of therapy,
including non-invasive methods, may
minimise the risks of paediatric in-
tensive care.
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Introduction
Does more medical care lead to improved outcome in
the context of critically ill children? In rural Papua New
Guinea, the introduction of oxygen for the treatment of
severe pneumonia resulted in a major decrease in child-
hood mortality [1]. In developing countries the introduc-
tion of highly specialised paediatric intensive care may
not lead to a drop in child mortality if scarce financial and
human resources are thereby channelled away from im-
proved quality of paediatric care in rural and district
hospitals [2, 3].
Even within developed countries, the “law of dimin-
ishing returns” suggests that, after a certain point, addi-
tional inputs may provide decreasing additional benefit
and that there may be a point at which additional growth
will actually cause harm [4]. The paediatric intensivist has
the choice of an increasing range of diagnostic and ther-
apeutic techniques, both invasive and non-invasive. While
increased diagnostic capacity may improve patient care, it
may cause harm by: identifying abnormalities that are not
actually causing problems; pressurising clinicians to treat
conditions that are asymptomatic; confusing clinicians by
the complexity of the diagnoses and by channelling re-
sources away from other clinically relevant issues. Like-
wise, while increased therapeutic capacity may improve
patient care, it may also be associated with increased ia-
trogenic disease and inappropriate utilisation of scarce
resources. Increased complexity of care alone may be
responsible for increased numbers of critical incidents, as
physicians are more likely to miss important issues and
the system becomes more liable to error. Neonatal and
paediatric intensive care is especially vulnerable in regard
to unintended consequences of care because the wide
range of diseases and ages makes standardised care dif-
ficult. Anonymous, voluntary critical incident monitoring
has shown the dimension of the problem [5] and in pae-
diatric intensive care patients receiving the most intensive
and invasive care are especially prone to critical incidents
[5].
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From the early days of paediatric and neonatal inten-
sive care serious side effects were associated with new
invasive therapies. In 1967 Northway et al. [6] described a
new “pulmonary disease following respirator therapy” in
neonates, which was later called bronchopulmonary dys-
plasia. Oxygen toxicity and baro- or volu-trauma associ-
ated with mechanical ventilation were shown to aggravate
lung injury [7], partly related to the therapeutic goal of
“normal” levels of oxygenation and ventilation.
Even generally accepted therapies have been shown to
be harmful. Exchange transfusions for a bilirubin of more
than 20 mg/dl were routinely undertaken in neonatal units
until the practice was reviewed [8]. Steroid treatment for
chronic lung disease of the newborn was almost routine
until recent associations with neurodevelopmental out-
come [9]. Even routine postoperative fluid management
may be deleterious [10]. The “normal” fluid maintenance
volumes used in many paediatric units are based on
Holliday and Segar’s work [11] and these volumes may
be inappropriately high in sick children who have much
lower caloric intake, lower urinary excretion rates and
decreased insensible losses.
The use of invasive monitoring has facilitated the de-
velopment of paediatric and neonatal intensive care.
However, there are problems in assessing the exact risk-
benefit ratio of many invasive interventions, e.g. pulmo-
nary artery catheters [12]. Invasive monitoring may be
inappropriate and actually harm patients. In a paediatric
intensive care unit, routine use of invasive monitoring of
infants with respiratory syncytial virus disease was asso-
ciated with increased laboratory testing, over-treatment
and significant increases in costs and morbidity without
improvement in outcome [13]. Similarly, Earle et al. [14]
showed that tracheal intubation and the use of central
venous catheters were associated with poor outcome for
low-risk patient groups in six ICUs in Central and South
America. In an adult intensive care unit, the presence of
an arterial line led to increased blood drawing [15] and in
a neonatal intensive care unit the presence of arterial
catheters increased the frequency of blood transfusions,
thereby exposing neonates to, probably, unnecessary risk
[16].
Even “safety systems” may add to risks: the increasing
number of alarm systems in intensive care may be prob-
lematic. It has been shown that over 94% of alarms
triggered in a paediatric intensive care unit are not clini-
cally important and may distract care givers from real
problems [17].
The clinical examples given above illustrate the pos-
sibility of harm from increased medical care. Problems in
system structure may also cause harm as reflected by
medication errors, which are a leading cause of iatrogenic
complications in neonatal and paediatric intensive care
[18]. The risks of neonatal and paediatric intensive care
may be minimised using several approaches, as discussed
below.
Use of safe and simple procedures
for appropriate periods
Most of the success of neonatal and paediatric intensive
care is based on an uncompromising, resolute approach to
the child with overt or potential respiratory, circulatory
or central nervous system failure. The first goal of this
pragmatic approach is to stabilise the vital parameters of
the seriously ill child according to the ABC concept (A:
airway, B: breathing, C: circulation) [19].
Some questions still remain with this pragmatic ap-
proach: Should oxygen be used for the resuscitation of
neonates [20]? What is the end point for volume resus-
citation in children with trauma and potential bleeding?
Recent experimental data challenge the approach of pro-
viding aggressive blood pressure support under these
circumstances [21]. Although intubation is said to be the
gold standard for airway control in children with head
trauma, there is data to suggest that urgent prehospital
intubation does not improve outcome and may lead to
complications [22, 23].
Diagnostic and therapeutic methods must be as safe,
simple, standardised and effective as possible. The pro-
cedures should be performed by suitably trained and ex-
perienced personnel. Adult data have shown that the risks
of central venous access are substantially increased if the
operator has less personal experience of the technique
[24]. This is likely to be true in children, too.
Once invasive techniques have been instituted, they
should be terminated as soon as possible. The evidence in
favour of such an approach has been shown for tracheal
intubation and central venous catheterisation. Complica-
tions of endotracheal intubation and mechanical ventila-
tion in infants and children are related to duration [25].
The fact that 47–78% of neonatal and paediatric patients
who have had unplanned extubations do not require re-
intubation [25, 26, 27, 28, 29, 30] suggests that ventilation
is frequently being prolonged unnecessarily. This may be
partly due to the association of failed extubation with
subsequent prolonged mechanical ventilation [31]. With
the use of central venous lines, vascular thrombosis [32]
and line-related infections [33] are major complications
that are related to the duration of placement.
Particular attention
to medication prescription patterns
Clinicians have become increasingly aware of unneces-
sary medication and the potential to harm patients. This
has been clearly shown for antibiotic use in neonatal and
paediatric intensive care [34]. In addition to the danger to
the patient to whom they are given, unnecessary antibi-
otics are potentially dangerous to other patients because
of the development of multi-resistant organisms.
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The number of medications given to a patient simul-
taneously has to be restricted because drug/drug-interac-
tions are not foreseeable even when relatively few med-
ications are prescribed. Furthermore, there is potential to
treat side effects of drugs with the application of more
drugs.
In paediatric intensive care, drug therapy is especially
prone to incidents [18, 35, 36, 37, 38, 39, 40, 41], but
amenable to organisational measures for improvement.
The drug delivery process comprises three stages and
errors may occur at each stage: prescription (wrongly or
illegibly prescribed or incorrectly transcribed onto the
medication chart, calculation errors and confusions of
units), preparation and administration. In administration
of the drug there may be problems with interpretation of
wrong or misleading drug labels or packaging [35]. The
following error types may then occur: dose too high or too
low, drug omitted or given too frequently, wrong route of
administration and wrong drug [35].
In this multi-stage process, interception plays an im-
portant role [35]. In order to improve their controlling
function, nurses should have drug booklets and perform
double checks on selected drugs. Furthermore, involving
pharmacists in reviewing drug orders has been shown to
significantly reduce the potential harm resulting from
errant medication orders [38, 42]. Computerised physi-
cian order entry with clinical decision support systems has
been shown to reduce the rate of errors [43, 44]. Pre-
scriptions written on a computer can be forced to be
legible and complete and applications can force con-
straints on clinicians’ choices regarding the (weight-de-
pendent) dose or route of administration. Using such a
system, a physician cannot enter an order for a lethal
overdose of a drug.
Given the number of drugs and the number of doses
administered to critically ill patients, error limits will
have to be considerably below 1% to avoid significant
numbers of daily errors. That requires a very well struc-
tured and monitored system.
Selection of appropriate aims of therapy
One of the problems of therapy has been the delineation
of the required end point and the cost of reaching that end
point. In paediatric cardiac surgery there has been an
evolution away from maintaining blood pressure to opti-
mising cardiac output and decreasing cardiac work. It is
likely that that sort of issue will arise in many other areas
of paediatric intensive care.
Physiological (healing) processes should be integrated
in treatment plans. In neonatal ICU the “minimal han-
dling” concept has been shown to be more successful than
more aggressive approaches [45]. Whenever possible,
natural organ functions should be maintained. Enteral
feeding is considerably safer (and cheaper) than intrave-
nous alimentation [46]. Spontaneous breathing is prefer-
able to muscle relaxation/fully mechanical respiratory
support whenever possible. The drawbacks of neuro-
muscular blocking agents include a fall in lung compli-
ance and functional residual capacity, a rise in airways
resistance [47], a reduction of joint mobility in premature
infants [48] and an association with the so-called critical
illness neuropathy [49].
The maintenance of normal body temperature has of-
ten been an end point for the use of paracetamol. Some
studies now suggest that fever may have a beneficial role
in infection [50], and the World Health Organisation
recommends that antipyretics be withheld in bacterial
sepsis [50].
Selection of appropriate modes of therapy including
non-invasive therapeutic and diagnostic methods
The application of early continuous positive airway pres-
sure (CPAP) by nasal prongs in babies with respiratory
distress syndrome (RDS) has been associated with a re-
duction in the requirement for mechanical ventilation and
in its complications [51], although the technique does not
improve the outcome with respect to mortality [52].
The World Health Organisation recommends the use
of nasal prongs and nasopharyngeal catheters as a safe
and efficient means of oxygen administration [53]. It has
been shown that these methods, applied to infants with
oxygen flows of 0.5–1.0 l/min, produce PEEP of up to
4 cmH2O [54, 55]. These levels of PEEP are safe (al-
though gastric distension is a potential complication if the
oxygen is poorly administered [56]) and a welcome by-
product because they may contribute to an improvement
in oxygenation by altering the viscoelastic properties of
the lung. The attributes “safe” and “efficient” are espe-
cially important in countries with limited resources for
patient monitoring, equipment and supplies, such as
medical oxygen. However, safe and simple methods are
equally useful in the industrialised world as they have the
potential to reduce the risks of therapy.
Gentler modes of ventilation have been successfully
introduced. With conventional ventilation, a high-PEEP-
small-tidal-volume-strategy has shown reduced mortality
due to acute respiratory distress syndrome in adults [57,
58]. High frequency ventilation, the extreme of small tidal
volume ventilation, has been shown to be effective in
preventing chronic lung disease in preterm infants suf-
fering from neonatal respiratory distress syndrome [59,
60]. Non-invasive positive pressure ventilation by either a
nasal or oral-nasal mask is increasingly used in children
with acute respiratory failure [61]. However, it has not
been established whether non-invasive positive pressure
ventilation can significantly decrease mortality or the
incidence of endotracheal intubation in paediatric patients
[61]. Non-invasive negative pressure ventilation is not
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Advances in medical technology have made it possible
to replace an increasing number of invasive, and thus
potentially harmful, monitoring devices by non-invasive
methods: pulse oximetry, transcutaneous PO2 and PCO2,
capnography, continuous electrocardiography to monitor
heart rate and inductance respiratory plethysmography to
monitor respiratory rate, oscillometric blood pressure
measurement (Dinamap) and cerebral function monitor-
ing (continuous EEG with a reduced number of electrodes
and combined with a slow chart recorder [62]). Still in the
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measure cardiac output [64]. Advances in bedside labo-
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number of parameters in minimal blood volumes. As an
example, capillary whole blood lactate measurements
(amperometric lactate biosensor, blood volume 0.04 ml)
in healthy and sick newborn babies agree excellently with
arterial values [65]. Therefore, even in very small new-
born infants, reliable lactate values can be easily obtained.
Pulse oximetry has become one of the most valuable
monitoring techniques in intensive care, anaesthesia and
emergency medicine for continuous evaluation of arterial
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the patient’s heart rate [66], which may be important
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Appropriate staffing
Despite all the advantages of non-invasive monitoring
delineated above, one has to ask the question: what is the
evidence that the use of all the technology is any better
than trained clinical monitoring? An indication of the
importance of the presence of appropriately trained nurs-
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amine patients, has been given in critical incident moni-
toring. The most important method of critical incident
detection was patient inspection; the rate of alarms
drawing staff’s attention to a critical incident was aston-
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10% in [5] and 8% in [70]).
In resource-rich, and resource-constrained communi-
ties, there may be a tendency to try and use equipment as
a means to limit expenditure on personnel. There is no
evidence that ICU equipment can replace trained staff and
increasing evidence that understaffing is associated with
poor outcome.
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